Trigeminal Neuralgia and the Upper Cervical Spine: What the Evidence Shows

Trigeminal neuralgia (TN) is a chronic pain condition affecting the trigeminal nerve, the main sensory nerve of the face. According to a clinical review on the National Institutes of Health's StatPearls platform, it produces sudden, unilateral, electric-shock-like pain lasting anywhere from a few seconds to about two minutes, most often in the cheek and jaw (the maxillary and mandibular branches of the nerve). Episodes are frequently triggered by ordinary activities — chewing, talking, brushing teeth, or a light touch to specific 'trigger zones' on the face — and rarely occur during sleep.

TN is uncommon but not rare. That same review reports an annual incidence of roughly 4 to 13 new cases per 100,000 people and a lifetime prevalence of about 0.16% to 0.3%, with women affected 1.5 to 1.7 times more often than men and onset typically occurring after age 50.

The most widely accepted explanation is vascular compression: a blood vessel — most often the superior cerebellar artery, implicated in an estimated 75% to 80% of compressive cases — presses on the trigeminal nerve root near the brainstem, according to StatPearls. Over time this is thought to wear away the nerve’s protective myelin coating, causing pain and touch signals to cross-talk in a way that produces the characteristic shock-like pain from otherwise ordinary stimulation.

First-line treatment is an anticonvulsant medication, usually carbamazepine or oxcarbazepine, which the American Association of Neurological Surgeons (AANS) notes controls pain for most people in the disease’s early stages. The same source is direct about a common complication, though: the effectiveness of carbamazepine decreases over time for many patients, sometimes requiring higher doses or additional medications that raise the risk of side effects such as dizziness, double vision, and drowsiness. When medication becomes ineffective or intolerable, the remaining options are more invasive — procedures such as microvascular decompression, which StatPearls reports has greater than 90% initial efficacy but which involves open surgery near the brainstem.

Diagnosis adds another layer of difficulty. AANS states plainly that TN "can be very difficult to diagnose, because there are no specific diagnostic tests" — the diagnosis rests on a patient’s description of the pain pattern and a clinical exam rather than a scan or blood test, which can draw out the path to an accurate diagnosis in the first place.

The trigeminal nerve’s pain-processing pathway inside the brainstem is called the spinal trigeminal nucleus, and its lowest segment — the pars caudalis, responsible for pain and temperature sensation from the face — extends downward until it becomes directly continuous with the dorsal horn of the spinal cord at approximately the C3 level, according to a StatPearls neuroanatomy review. In plain terms, the same neurons that process facial pain signals are structurally connected to the sensory neurons of the upper cervical spine.

This anatomical overlap, sometimes called the trigeminocervical complex, is the same basic mechanism researchers point to when explaining how neck-related dysfunction can contribute to migraine and cervicogenic headache. It is a documented, real anatomical connection — not a hypothesis unique to chiropractic care — though anatomical plausibility on its own does not prove that treating the neck will change trigeminal nerve pain in a given patient. It simply explains why the question is worth asking.

Published research connecting upper cervical care directly to trigeminal neuralgia outcomes is limited, and what exists is case-report level. One case report published in the Journal of the Canadian Chiropractic Association describes a 68-year-old woman with 7.5 years of trigeminal neuralgia — previously unresponsive to acupuncture, physical therapy, and anticonvulsant medication — who received upper cervical chiropractic care targeting misalignment at C1 and C2. Over about 18 months of care, her symptoms were reported to have nearly fully resolved. As a single case report, this cannot establish that upper cervical care caused the improvement: the patient had also stopped several other treatments during that period, there was no control group, and a single case cannot be generalized to how any other patient would respond.

In our own experience providing Advanced Orthogonal upper cervical care — a precision, imaging-based correction of the same C1-C2 junction discussed above — we regularly see patients with trigeminal neuralgia report a real decrease in how often and how intensely their facial pain flares over the course of consistent care, including patients whose medication had already stopped working well for them. This is our own clinical observation from patients in this practice, not a claim drawn from the published research above, and outcomes vary from patient to patient — but it is consistent with the direction the case-report literature points.

If carbamazepine or oxcarbazepine has stopped working as well as it once did, or side effects have become hard to tolerate, that is worth raising directly with the prescribing physician before considering any other option — a medication adjustment or specialist referral may resolve the issue on its own. For patients who have already had that conversation and are still searching for something more, a clinical evaluation that specifically examines the upper cervical spine is a reasonable next step to explore, given the anatomical connection and the case-level evidence described above.

This summary does not constitute medical advice and is not a substitute for an individualized clinical evaluation. An upper cervical evaluation typically starts with precise imaging of the C1-C2 junction to determine whether misalignment is present before any correction is recommended.